Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

July 20, 2017

Painkillers for Cancer-Related Pain

Author(s):

Barbara Carlos

For years, the news has been full of stories about opioid addiction. I am just glad that painkillers that actually killed the pain were available when I needed them.

Before I had cancer, my experience with pain was limited. I was healthy and never broke a bone. I had my appendix removed when I was a child, and my tonsils were gone too, but those events occurred so long ago that they are barely a memory. I had suffered from crippling migraines in my 30s and 40s but their pain had diminished as I got older. Now I know what pain truly is.

I don’t remember post-surgical pain being discussed when I saw the surgeon just before my mastectomy. Perhaps she or the nurse brought it up but I was still focused on the abstract word “cancer” and the alien notion of voluntarily allowing her to remove a breast, even if it did have cancer. But that afternoon, someone did say something about painkillers. In the few days between that office visit and surgery, whenever the idea of pain entered my mind, I quickly banished it. I had other things to think about and I didn’t want to think about pain.

When I woke up in recovery, I felt fine, just like I had taken a nice nap. I was moved to my room and felt well enough to walk around. My first visitors arrived in the form of my best friend and her husband, whose first wife coincidentally had died of breast cancer a few years before. They didn’t stay long because they didn’t want to wear me out and probably because all three of us were walking uncertain ground. After they left, my supper came in. I always have an appetite and gladly chowed down since it had been a long time since dinner the night before. My sister and mother arrived but also didn’t stay long. I became aware of the pain after they left. I guess whatever they gave me during surgery had finally worn off.

I buzzed the nurse and told her about the pain. She promptly produced a little pill. About an hour later, I buzzed again and asked when the pill was going to start working. I noticed that my breathing was rapid. I felt physically stressed and could think of nothing but pain, pain, PAIN. The nurse called the resident in and a second pill was authorized. That did the trick.

I was relieved to find that my health care providers believed that I should be pain-free and gave me the tools to be free of pain. The next day, I filled a pain prescription as I left the hospital. I’m a bit of a dork and always read the information that comes with medication. That’s how I found out it was oxycodone and that oxycodone was an opioid. Until then, I didn’t know the name of any opioids. Stories about opioid addiction popped into my head but I didn’t care. Oxycodone became my new best friend. Opioid or non-opioid didn’t matter to me as long as I had something that worked. And Oxy worked.

Over the next week or so I went from two pills down to one and then none. I cannot emphasize the relief I felt that my pain was taken seriously and dealt with effectively. I had so many other things to deal with and wouldn’t have been able to deal with anything if all I could focus on was pain. I understood why people are afraid of pain. It can be mind-numbingly all-consuming.

I began chemo the month after surgery. I was on a three-week cycle and the day after my cocktail, I would start a series of ten daily injections of Neupogen to stimulate my bone marrow. The day after the first injection, I could barely get out of bed to go to the bathroom due to severe joint pain the likes of which I had never imagined possible. I called oncology and was advised to take the oxycodone pills left over from the surgery. The pills helped, but it was a rough weekend.

On Monday, I wasn’t up to driving so I had a nephew take me to the oncologist. My doctor set up a plan for pain management, alternating with oxycodone and over-the-counter drugs, with oxycodone started before the pain from the injections kicked in. With each chemo cycle, the bone-breaking pain lasted for most of the days of the Neupogen injections. Even with my new best friend, I was barely able to function on those days.

Chemo ended and so did the injections. No more pain, so no more pills.

A month later and it was radiation time.

It’s funny how the body works. Normally you aren’t consciously aware of movement. You just move and that’s that. But even moving my right arm slightly engaged what little muscle remained on my left chest. I must have been a sight to see — still bald from chemo with no eyebrows or eyelashes, staggering when I walked due to neuropathy and keeping my left arm pinned to my chest to minimize movement and therefore minimize pain. Now I can say it was the worst sunburn I ever had, but at the time it wasn’t a laughing matter. After two weeks of radiation, there was an open gash on my chest an inch wide and eight inches long. Talking hurt. Breathing hurt. Walking hurt. Wearing a seatbelt hurt. Clothing really hurt. Well, if you have been there, you know what I mean. If you haven’t been there, I am sure you can imagine. Back to my friend Oxy for a month.

I know opioid addiction is a problem. From personal experience, I know that when you have a lot of pain, taking opioids can diminish the pain enough for you to focus on other things, like sleeping for a few hours, fixing and eating a meal, going to work or doing laundry so you have some clean clothes to wear to work. I have been told that when you don’t have a lot of pain, taking opioids can make you feel really, really good and therein lies the root of the problem.

I feel for those who suffer from this addiction and for their loved ones who suffer along with them. Greater minds than mine will have to solve that problem and related issues. I am just glad that relief from pain was available for me when I needed it and I hope that it will always be available for me and for others who need it on a limited basis.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. Evens.
Uniting Pediatric and Adult Oncologists to Advance AYA Lymphoma Care
Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.
Expert Offers Surveillance, Lifestyle Guidance After CRC, Anal Cancer
Image of Dr. D'sa
Understanding the Evolution of Waldenström Macroglobulinemia Treatment
Image of doctor.
Early Arterial Thrombosis May Signal Future Cancer Risk
Image of Dr. Deville.
What are the Long-Term Side Effects of Proton Therapy in Prostate Cancer?
Image of carly.
Facing Cancer as an AYA and Navigating Fertility Preservation Choices
Image of doctor.
Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC
Image of man.
Understanding Unique Treatment Options Across Bladder Cancer Care
Image of kelly.
Preparing For Survivorship After Lymphoma Treatment in AYA PatientsPreparing For Survivorship After Lymphoma Treatment in AYA Patients
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function
Related Content
Advertisement
HEATHER PATENAUDE, B.S.N., RN
May 23rd 2025

True Grit: The Spirit of an Extraordinary Healer

Pamela O’Neil,M.S.N.,NP-C,AOCNP
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of kelly.
May 23rd 2025

Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

Kelly Irvin
I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of blood cells.
May 23rd 2025

Breaking Down Treatment Variables in AYA Patients With Cancer

Ryan Scott
Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on lymphoma care.
Itovebi plus Ibrance and Faslodex improved overall survival in patients with HR+, HER2– breast cancer versus placebo: © stock.adobe.com.
May 22nd 2025

Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

Caroline Seymour
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Related Content
Advertisement
HEATHER PATENAUDE, B.S.N., RN
May 23rd 2025

True Grit: The Spirit of an Extraordinary Healer

Pamela O’Neil,M.S.N.,NP-C,AOCNP
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of kelly.
May 23rd 2025

Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

Kelly Irvin
I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of blood cells.
May 23rd 2025

Breaking Down Treatment Variables in AYA Patients With Cancer

Ryan Scott
Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on lymphoma care.
Itovebi plus Ibrance and Faslodex improved overall survival in patients with HR+, HER2– breast cancer versus placebo: © stock.adobe.com.
May 22nd 2025

Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

Caroline Seymour
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Advertisement
Advertisement
Advertisement
x
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.